The Transcription Factor Snail Mediates Epithelial to Mesenchymal Transitions by Repression of Estrogen Receptor-alpha
Overview
Molecular Biology
Affiliations
The estrogen receptor (ER)-alpha (ESR1) is a key regulatory molecule in mammary epithelial cell development. Loss of ER-alpha in breast cancer is correlated with poor prognosis, increased recurrence after treatment, and an elevated incidence of metastasis. A proposed molecular pathway by which ER-alpha acts to constrain invasive growth in breast cancer cells involves direct, ER-alpha-dependent expression of metastasis-associated protein 3, a cell-type-specific component of the Mi-2/NuRD chromatin remodeling complex. MTA3 in turn represses expression of Snail, a transcription factor linked to epithelial to mesenchymal transition and cancer metastasis. To elucidate its role(s) in epithelial to mesenchymal transition (EMT), we expressed Snail in the noninvasive, ER-alpha-positive MCF-7 cell line. Snail expression led to decreased cell-cell adhesion and increased cell invasiveness. Furthermore, we observed loss of ER-alpha expression at both the RNA and protein level that was accompanied by direct interaction of Snail with regulatory DNA sequences at the ESR1 locus. A consequence of loss of ER-alpha function in this system was the increased abundance of key components of the TGF-beta signaling pathway. Thus, cross-talk among ER-alpha, Snail, and the TGF-beta pathway appears to control critical phenotypic properties of breast cancer cells.
Andreeva O, Sorokin D, Vinokurova S, Kopnin P, Elkina N, Katargin A Cancer Drug Resist. 2024; 7:48.
PMID: 39624078 PMC: 11609143. DOI: 10.20517/cdr.2024.69.
Regulation of ERα-dependent breast cancer metastasis by a miR-29a signaling.
Lu J, Zhao Q, Guo Y, Li D, Xie H, Liu C J Exp Clin Cancer Res. 2023; 42(1):93.
PMID: 37081505 PMC: 10116798. DOI: 10.1186/s13046-023-02665-6.
To N, Truong V, Ediriweera M, Cho S Int J Mol Sci. 2022; 23(19).
PMID: 36232636 PMC: 9570034. DOI: 10.3390/ijms231911340.
ATAC-seq Optimization for Cancer Epigenetics Research.
Cooper M, Ray A, Bhattacharya A, Dhasarathy A, Takaku M J Vis Exp. 2022; (184).
PMID: 35848835 PMC: 10064075. DOI: 10.3791/64242.
Ponnusamy L, Mahalingaiah P, Chang Y, Singh K Cancer Drug Resist. 2022; 2(2):297-312.
PMID: 35582717 PMC: 8992622. DOI: 10.20517/cdr.2018.11.